noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Johnson & Johnson

07/30/2024 | Press release | Distributed by Public on 07/30/2024 16:44

DARZALEX FASPRO® (daratumumab and hyaluronidase fihj) based quadruplet regimen approved in the U.S. for patients with newly diagnosed multiple myeloma who are transplant eligible

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Johnson & Johnson | News | Health | Science | Research | Company News | Business Announcement | Products and Services | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Six Swiss Exchange | Sao Paulo Stock Exchange (B3) | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Santiago Stock Exchange | Bolsa Mexicana de Valores (BMV) | Buenos Aires Stock Exchange (BCBA) | Lima Stock Exchange (BVL) | Colombia Securities Exchange | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Bolsa Electrónica de Chile | Cboe BZX Exchange | Cboe BXE Europe | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | Investors Exchange (IEX) | EuroTLX | Bolsa Institucional de Valores (BIVA) | Hannover Stock Exchange | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago | Turquoise

Back

Download the original document